Hematology CPC - PowerPoint PPT Presentation

1 / 53
About This Presentation
Title:

Hematology CPC

Description:

Progressive numbness of his fingers and toes ascending to mid shin and mid ... Slow and clumsy toe tapping. Decreased vibratory sensation and proprioception ... – PowerPoint PPT presentation

Number of Views:959
Avg rating:3.0/5.0
Slides: 54
Provided by: sw47
Category:
Tags: cpc | hematology | toes

less

Transcript and Presenter's Notes

Title: Hematology CPC


1
Hematology CPC
  • Bao Le, DO
  • Internal Medicine
  • October 9 , 2007

2
Objectives
  • Presenting a case
  • Bariatric surgery
  • Neurologic complications of Bariatric surgery
  • Peripheral neuropathy
  • Macrocytic anemia
  • Myelodysplastic syndrome
  • Conclusion

3
Case
  • CC Sore throat.
  • HPI A 43 y/o man presents to the ER with
  • A 3-day history of mouth and throat pain
    associated with a white coating.
  • Temperature of 102 F at home with chills.
  • Progressively fatigued over past 5 months.
  • Overt dyspnea on exertion with walking 10 yards.
  • Progressive numbness of his fingers and toes
    ascending to mid shin and mid forearm over one
    year.
  • He denies
  • Changes in mentation or tongue soreness.
  • Bright red blood per rectum or black tarry
    stools.

4
Case (Cont)
  • ? PMH
  • Bariatric surgery at the age of 25, in 1987.
  • Weighed 541 lbs prior to the surgery.
  • PSH
  • Bariatric surgery.
  • Family hx
  • No blood dyscrasias.
  • Positive for obesity.
  • Social hx
  • Worked as a laborer.
  • No heavy metal exposure.
  • 10 pack/year tobac history.
  • Less than 1 drink EtOH/day.
  • Medications
  • B12 injections.
  • Iron 325 mg BID.
  • MVI.
  • ROS
  • Pertinent per HPI.

5
Case (Cont)
  • Physical Exam
  • VS 110/75, 105, 97 RA, 101.2 F, 240 lbs, 61
  • GEN toxic, uncomfortable, no dyspnea with
    conversation.
  • HEENT oral mucosa coated with thrush, tongue
    appears normal, non-icteric sclera, conjuctiva
    was pale.
  • NECK prominent carotid pulse, no thrill or
    bruit, no lymphadenopathy.
  • CV tachycardic, S1 S2, no m/g/rubs.
  • RESP clear.
  • ABD mod obese, no TTP, no organomegaly.

6
Case (Cont)
  • Physical Exam (cont)
  • EXT chronic venous insufficiency changes.
  • DERM no rashes.
  • PSYCH appropriate.
  • NEURO
  • distal reflexes decreased.
  • distal sensation decreased.
  • able to ambulate.
  • normal speech pattern.

7
Case (Cont)
  • LAB
  • G 20, M 15, L 65
  • MCV 108, RDW 13
  • Ferritin lt 10 (39-150)
  • B12 gt 700 pg/mL
  • MMA not elevated
  • Folic acid normal
  • LDH 210 (60-200)
  • Liver and Renal normal
  • PBS
  • Severe leukopenia
  • Few (lt 1 per HPF/avg) hypersegmented neutrophils
  • No blasts
  • Macrocytic RBC without fragmentation
  • Bone Marrow
  • Hypercellular 70
  • Trilineage dysplasia
  • Ringed sideroblasts
  • lt 5 blasts
  • Cytogenetics normal

5.6
1000
65000
8
Case Overview
Neurological deficits
Sore throat DOE/Fatigue
43 y/o man
Constitutional symptoms
Hematologic abnormalities Pancytopenia
Bariatric surgery
9
Obesity and Bariatric Surgery
  • According to 2000 US Census 63 million adult
    Americans with obesity, BMI 30, and 10.5
    million with morbid obesity, BMI 40.
  • Annual obesity-related medical expenditures were
    substantial.
  • The rise in the prevalence of obesity is
    associated with increases in the prevalence of
    obesity comorbidities.
  • The loss of life expectancy due to obesity is
    profound.
  • In 1991, NIH established bariatric surgery
    guidelines BMI 40 or 35 in the presence of
    significant comorbidities.

10
Gastrointestinal Tract
Calcium Iron, Phosphorus, zinc Copper, Vitamins
B12, Zinc Copper, Phosphorus Vitamins
11
Bariatric surgery techniques
12
  • The prospective, controlled Swedish Obese
    Subjects study involved 4047 obese subjects.
  • Age 37-60, BMI gt 34 for male, BMI gt 38 for
    female.
  • Conventional treatment 2037
  • Bariatric surgery 2010
  • Average follow-up 10.9 years
  • Surgical group had a hazard ratio of 0.76
    compared to control group ( 95 confidence
    interval, 0.59 0.99, P 0.04)

13
  • 136 articles and 22094 patients.
  • JAMA, October 13, 2004 - Vol 292.
  • Results
  • Resolution of DM 76.8
  • Resolution of HTN 61.7
  • Improvement of lipid 83
  • Resolution of OSA 85.7

14
Neurologic Complication of Bariatric
Surgery
  • Encephalopathy
  • Behavior abnormalities
  • Cranial nerve palsies
  • Ataxia
  • Seizure
  • Myelopathy
  • Plexopathy
  • Mononeuropathy
  • Myopathy
  • Myotonia
  • Peripheral neuropathy

15
  • Department of Neurology, Mayo Clinic and Mayo
    Foundation, Rochester, MN.
  • Neurology 2004 631462-1470.
  • Retrospective review study, 1985 - 2001.
  • Open Cholecystectomy 300 BS 435.

  • BS 16
  • Peripheral Neuropathy P lt 0.001

  • Open Chol 3

16
  • Neuropathic characteristics of PN after BS

Sensory-predominant PN Insidious onset Chronic
course Distal LE/UE
Mononeuropathy Carpal Tunnel Syndrome
Radiculoplexus neuropathy Lumbosacral Cervical
17
  • Risk factors for PN after BS
  • A greater absolute weight loss
  • A faster rate of weight loss
  • A lower postsurgery BMI
  • Lower serum albumin
  • Lower transferrin concentrations
  • Prolonged postsurgery GI symptoms
  • Less MVI and Ca supplement
  • Not attending nutritional clinics

18
Symmetric Polyneuropathies
  • Inflammatory/Immune-Mediated Neuropathies
  • Guillain-Barre syndrome
  • Chronic inflammatory demyelinating
    polyradiculoneuropathy
  • Vasculitic neuropathy
  • Sarcoid neuropathy
  • Neuropathies associated with connective tissue
    disease
  • Toxic Neuropathies
  • Drugs, metals, alcohol
  • Neuropathies Associated with Cancer
  • Remote effects of cancer
  • Direct tumor infiltration

19
Symmetric Polyneuropathies
  • Inherited Neuropathies
  • Hereditary motor sensory neuropathies
  • Giant axonal neuropathy
  • Porphyric neuropathies
  • Lysosomal enzyme deficiency (Fabry disease)
  • Lipoprotein disorders
  • Neuropathies Associated with Infection
  • HIV
  • Leprosy
  • Lyme disease
  • Neuropathies Associated with Organ System Failure
  • Kidney, lung, liver
  • Critical illness polyneuropathy
  • Organ transplantation
  • Diabetic Polyneuropathy
  • Vitamin Deficiencies
  • Cobalamin (B12)
  • Vitamin E
  • Thiamine (B1)
  • Pyridoxine (B6)

20
Neurologic Manifestations of Cobalamin (B12)
Deficiency
  • Distal paresthesias
  • Unsteady gait
  • Deficit in vibratory sensation and proprioception
  • Diffuse hyperreflexia
  • Loss of reflex at ankle
  • Neurobehavioral changes apathy, irritability,
    memory loss.

21
Neurologic Manifestations of Vitamin E Deficiency
  • Progressive gait ataxia
  • Night blindness
  • Loss of vibratory sensation and proprioception
  • Absent reflexes
  • Ptosis/Ophthalmoplegia
  • Dysarthric speech
  • Intention tremor

22
Neurologic Manifestations of Thiamine (B1)
Deficiency
  • Fatigue/Irritability
  • Distal paresthesias affecting feet with burning
    pain
  • Distal sensory loss
  • Hyporeflexia
  • Wernicke-Korsakoff syndrome mental confusion,
    ataxia, ophthalmoplegia
  • Cerebellar degeneration

23
Neurologic Manifestations of Pyridoxine (B6)
Deficiency
  • Paresthesias in distal limbs
  • Gait instability
  • Distal areflexia with normal muscle strength
  • Lhermitte sign (Barber Chair Phenomenon)
  • EMG
  • Absent or reduced sensory nerve potentials
  • Normal motor nerve conduction

24
Gastrointestinal Tract
Calcium Iron, Phosphorus, zinc Copper, Vitamins
B12, Zinc Copper, Phosphorus Vitamins
25
  • Department of Neurology and Division of
    Gastroenterology and Hepatology, Mayo Clinic,
    Rochester, MN.
  • Neurology 20046333-39
  • Chart review of 13 patients with known copper
    deficiency and neurologic deficits.

26
(No Transcript)
27
  • 45 y/o woman
  • Persistent LE paresthesias and difficulty
    ambulating
  • PE Marked pallor and palpable spleen
  • Neuro
  • Hyperactive reflexes
  • Markedly decreased vibratory sense LE
  • Extremely ataxic gait
  • Cognition normal
  • BM
  • Hypercellular
  • Ringed sideroblasts
  • 45 y/o man
  • 4-month hands and feet paresthesias
  • Progressive weakness, exertional dyspnea,
    difficulty ambulating
  • PE Marked pallor and mild hepatosplenomegaly
  • Neuro
  • Slow and clumsy toe tapping
  • Decreased vibratory sensation and proprioception
  • Marked truncal ataxia
  • Brisk reflexes

28
(No Transcript)
29
Copper Deficiency Causes Demyelination
2 Atoms of Copper
O2
?
Superoxide Dismutase
O2
H2O2
Oxidadive damages DNA Proteins Lipids
Demyelination
30
Macrocytic Anemia
  • Drugs
  • Alcoholism
  • Reticulocytosis
  • Liver disease
  • Hypothyroidism
  • Vitamin B12 deficiency
  • Folate deficiency
  • Multiple myeloma
  • Aplastic anemia
  • Acute leukemia
  • Myelodysplastic syndrome

Chemotherapeutic agents
Diuretics Cyclophosphamide
Triamterene Hydroxyurea
Anticonvulsant agents Methotrexate
Phenytoin Azathioprine
Primidone Mercaptopurine
Valproic acid 5-Fluoracil
Anti-inflammatory Antiretroviral
Sulfasalazine Zidovudine

Stavudine Hypoglycemia Metformin Antimicrobials
Pyrimethamine Sulfamethoxazole Trimethoprim V
alacyclovir
31
Myelodysplastic Syndrome
  • MDS comprises a heterogeneous group of malignant
    stem cell disorders characterized by dysplastic
    and ineffective blood cell production.
  • These disorders may occur de novo or arise years
    after exposure to potentially mutagenic therapy.
  • The precise incidence of de novo MDS is not
    known.
  • MDS manifests as symptomatic anemia (60-80),
    neutropenia (50-60), and thrombocytopenia
    (40-60).
  • Clinical presentations
  • Incidental findings on routine laboratory
    studies.
  • Fatigue, malaise, and a general sense of
    tiredness.
  • Petechiae, ecchymoses, nose and gum bleeding.
  • Fever or shock.

32
Myelodysplastic Syndrome
  • Physical Exam
  • Pale, petechiae, purpura
  • Hepatomegaly, splenomegaly, LN
  • Tachycardia, fever
  • PBS
  • Macrocytic with oval-shaped RBC
  • Basophilic stippling, Howell-Jolly bodies
  • Neutropenia
  • Thrombocytopenia
  • Bone Marrow
  • Hypercellularity with trilineage dysplastic
    changes
  • Ringed sideroblasts
  • Cytogenetics
  • Normal, 5q-, 7q-, 20q-, trisomy 8

33
FAB Criteria for MDS Subgroups
34
Myelodysplastic Syndrome
35
Myelodysplastic Syndrome
36
Myelodysplastic Syndrome
  • Treatment
  • Supportive care
  • Transfusion as needed
  • Iron chelation
  • Low-intensity therapy
  • Anemia EPO G-CSF (ringed sideroblast and serum
    Epo levels lt 500 mU/mL)
  • Neutropenia G-CSF or GM-CSF
  • Thrompocytopenia IL-11, thrombopoietin, danazol
  • 5-azacytidine
  • Immunosuppressive therapy ATG and cyclosporine
  • Anti-TNF, anti-angiogenesis agents
  • High-intensity therapy
  • Chemotherapy
  • Hemopoietic stem cell transplantation (HSCT)

37
Copper Deficiency
Central/peripheral neuropathy
Copper Deficiency
?
MDS
Anemia Leukopenia
38
  • Baylor College of Medicine, Houston, Tx and the
    Department of Pathology, University of Alabama at
    Birmingham.
  • Blood, 15 August 2002. Vol 22, number 4
    1493-1495.
  • 44 y/o woman with h/o gastric resection with
    Billroth II for peptic ulcer who presents with
    macrocytic anemia and leukopenia.
  • WBC 1.5 with 19 neutrophils, hemoglobin 6.4
    g/dl, MCV 102, platelet count 192.
  • B12, folate, and ferritin were elevated.
  • PBS macrocytic, oval shaped RBC
  • Bone marrow dyserythropoiesis, dysmyelopoiesis,
    ringed sideroblasts, and prominent hemosiderin in
    plasma cell.
  • Cytogenetic studies were normal.

39
  • She was diagnosed with MDS, FAB subtype
    refractory anemia with ringed sideroblasts
    (RARS).
  • Treated with G-CSF and EPO.
  • Referred for BM transplantation.
  • Treated with 6 weeks of IV copper chloride.
  • Normalized hematologic abnormalities and bone
    marrow aspiration.

40
  • Department of Neurology, University of Michigan,
    MI.
  • Arch Neurol 2003 601303-1306.
  • 46 y/o male c/o
  • CP/SOB
  • Progressive numbness and weakness of both LE
  • Poor balance
  • Neurologic Exam
  • Intact cranial nerves
  • Normal mentation
  • Brisk DTRs in LEs
  • Bilateral plantar flexor response
  • Markedly reduced vibratory sensation and
    propioception
  • Wide based gait

41
  • Lab
  • Hemoglobin 7.9 g/dL
  • Copper lt 10 ug/dL (80 120 ug/dL)
  • Zinc 184 ug/dL (80 120 ug/dL)
  • 24-hour urine copper 0.04 mg/d ( 0.03 0.05
    mg/d)
  • 24-hour urine zinc 5.01 mg/d ( 0.24 0.4 mg/d)
  • Treatment
  • Started copper supplement 2 mg/d
  • Normalize hematologic abnormalities
  • Worsening neurologic deficits
  • Increased to 8 mg/d
  • Improving neurologic deficits

42
Hyperzincemia Induces Copper Deficiency
  • ? Zinc
  • ? Metallothionein
  • Metallothionein competes
    Copper receptors in GI
  • ? GI Copper Absorption
  • Copper Deficiency

43
Iron Metabolism Depends on Copper
Copper (6 atoms)
Ceruloplasmin
Ferrous Iron Fe
Ferric Iron Fe
Transferrin
Apotransferrin Apo Tf
Abnormal iron metabolism
44
  • 82 of 3-5 day-old pigs
  • Control with no iron
  • Control with PO iron
  • Control with IM iron
  • Exp with PO iron
  • Exp with IM iron
  • Study over 14 weeks

45
(No Transcript)
46
(No Transcript)
47
Conclusion
Abnormal iron metabolism
Copper deficiency
Peripheral polyneuropathy
Myelodysplastic syndrome RARS
Neutropenia
Macrocytic anemia
Thrombocytopenia
Neutropenic fever
Fatigue, DOE
48
Lab/Study
Blood and Urine Culture
  • Dr. Hurley
  • Dr. Starr
  • Copper and Ceruloplasmin Level
  • Complete iron panel
  • Dr. Clark

Rectal Exam!!!
EMG
49
References
  • Xylina T. Gregg, Vishnu Reddy, and Josef T.
    Prchal. Copper deficiency masquerading as
    myelodysplastic syndrome. Blood 2002 100
    1493-1495.
  • P. Thaisetthawatkul, M.L. Collazo-Clavell, M.G.
    Sarr, J.E. Norell, and P.J.B. Dyck. A controlled
    study of peripheral neuropathy after bariatric
    surgery. Neurology 2004 63 1462-1470.
  • Katalin Juhasz-Pocsine, Stacy A. Rudnicki, Robert
    L. Archer, Sami I. Harik. Neurlogic complications
    of gastric bypass surgery for morbid obesity.
    Neurology 2007681843-1850.
  • Jerry R. Mendell, John T. Kissel, David R.
    Cornblath. Diagnosis and Management of Peripheral
    Nerve Disorders. Oxford University Press, Inc.
    New York, NY, 2001.
  • Henry Buchwald, Yoav Avidor, Eugene Braunwald,
    Michael K. Jensen, Walter Pories, Kyle Fahrbach,
    Karen Schoelles. Bariatric Surgery. JAMA
    20042921724-1728.
  • Neeraj Kumar, John B. Gross, and Eric Ahlskog.
    Copper deficiency myelopathy porduces a clinical
    picture like subacute combined degeneration.
    Neurology 20046333-39.
  • P Peter L. Greenberg, Neal S. Young, and Norbert
    Gattermann. Myelodysplastic Syndromes. Hematology
    2002 136-161.
  • G. Richard Lee, Sergio Nacht, John N. Lukens, and
    G. E. Cartwright. Iron Metabolism in
    Copper-Deficient Swine. The Journal of Clinical
    Investigation 1968 472058-2069.
  • Florence Aslinia, Joseph J. Mazza, Steven H.
    Yale. Megaloblastic Anemia and Other Causes of
    Macrocytosis. Clinical Medicine Research
    20064 236-241.
  • Edward H. Livingston. Complications of Bariatric
    Surgery. Surgical clinics of North America
    200585853-868.
  • C.I. Prodan, N.R. Holland, P.J. Wisdom, S.A.
    Burstein, S.S. Bottomley. CNS Demyelination
    Associated with copper Deficiency and
    Hyperzincemia. Neurology 2002591453-1456.
  • Neeraj Kumar, John B. Gross, J. Eric Ahlskog.
    Myelopathy due to Copper Deficiency. Neurology
    200361 273-274.
  • Peter Hedera, John K. Fink, Paula L. Bockenstedt,
    George J. Brewer. Myelopolyneuropathy and
    Pancytopenia due to copper Deficiency and High
    Zinc Levels of Unknown Origin. Arch Neurol
    2003601303-1306.

50
Thank you! Questions?
51
Trivia
  • Jon Brower Minnoch (USA, 1941-1983).
  • Weights 1397 lbs (635 kg).
  • Heaviest person.

52
Trivia
  • Manuel Uribe from Monterrey, Mexico.
  • 40 years old and weights 1225 lbs.
  • In March 2006, underwent most extreme BS in
    Italy.

53
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com